# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-16 | **更新时间**: 06:47 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- *当前暂无过去 24 小时内的相关重磅全球资讯。*

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[16:28]` **日本罕见病基因治疗药“Elevidys”纳入医保 定价约3.05亿日元创国内最高药价** [🔗阅读原文](https://news.google.com/rss/articles/CBMiigFBVV95cUxPVWl0Z0hoTzlia3pzX3FvcENic1BnYl9VM2Y4MW54V2RoMGlkejcxTERKR0Zfcl9lOTRZN09TS2I4akszcGpYemt6eVUwU2YxVU1yd1BlV3VCYkZhMnVZREdDcUdqYXdmaWRfZ3ZwSktGNTVSdV9iM1dndUsyd0dmUVBNZzA3b2wzY1E?oc=5)
- `[07:20]` **脊髓损伤患者再次站立！中山三院创新 iPSC 细胞治疗临床研究取得可喜疗效！** [🔗阅读原文](https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcDJ5RmJaVTRPNWt2Y3RKczNZVFJUZ1JqeDdMeHdnamw3Mmd6UWpXcllhR3ktOHBKU1VZcnVzWV9SVVVlRHdvdWJ1elBHQVFfUTFfbmpuRDlySnFUVkpEY0hBWVJJLTZwdnBXd1JWYTc0N2VpaEhTSmJjM2VSLVFNTld1STJuRFFVUTRJ?oc=5)
- `[07:20]` **全球进展再+1，睿健 NouvNeu001 顺利完成美国临床 II 期首例受试者给药** [🔗阅读原文](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPdF9MbHdFNmFFaDItLWdYcHFmbTRZdUlScVhJb2tWTEhkbzNkVWNieVdKODYtSGF0UTdPOElwNERsRjBxQkpvUDJ2MmxSNTkySkhqWnRYTm5vY2FvU0RYLUpCRm93SDE4SGRSYnRjcDg1Y1k0OHFuY2FnQmZJcnRoZW9KcWpTVXRENmJj?oc=5)
